Point72 Asset Management
BIIB icon

Point72 Asset Management’s Biogen BIIB Stock Holding History

Point72 Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.8K Buy
+300
New +$57.4K ﹤0.01% 3762

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Asset Management's BIIB Position: Q2 2026 in Review

Point72 Asset Management reduced its Biogen (BIIB) stake by 89% in Q2 2026, selling an estimated $138M and leaving 88,149 shares worth $19M. The position accounts for 0.02% of the portfolio, ranked #920.

Point72 Asset Management first reported a position in BIIB in Q2 2014 and has held it in 35 quarters since. The position peaked at $543M in Q3 2025. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Point72 Asset Management held 88,149 shares of Biogen worth $19M as of Q2 2026.
  • Point72 Asset Management sold 721,468 Biogen shares in Q2 2026, an estimated $138M.
  • Biogen made up 0.02% of Point72 Asset Management's portfolio in Q2 2026, its #920 holding.
  • Point72 Asset Management first reported a position in Biogen in Q2 2014 and has held it in 35 quarters since.
  • Point72 Asset Management's Biogen position peaked at $543M in Q3 2025.
  • 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.